
Pediatric Endocrinologist

No OPD information available
Marshall-Smith Syndrome
Micrognathia
Miller Syndrome
Omphalocele
Septo-Optic Dysplasia
Umbilical Hernia
Acromicric Dysplasia
Autism Spectrum Disorder
Axenfeld-Rieger Syndrome
Coffin-Siris Syndrome
Congenital Hypothyroidism
Epilepsy in Children
Gigantism
Hernia
Hypothyroidism
Hypotonia
Increased Head Circumference
Neurofibromatosis
Neurofibromatosis Type 1 (NF1)
Sotos Syndrome
Weaver Syndrome
Jan E. Liebelt is a healthcare provider who helps people with different health conditions like Marshall-Smith Syndrome, Micrognathia, Miller Syndrome, and many others. They also work with patients who have Autism Spectrum Disorder, epilepsy, and other medical issues. Liebelt is skilled in treating various conditions and disorders to help improve patients' health.
Liebelt communicates with patients in a caring and understanding way, which helps patients feel comfortable and trust their care. Patients trust Liebelt because they listen carefully to their concerns and provide clear explanations about their health and treatment options.
Liebelt stays updated with the latest medical knowledge and research to ensure they provide the best care possible to their patients. By staying informed about new treatments and technologies, Liebelt can offer the most effective and up-to-date care.
Liebelt works closely with other medical professionals to collaborate on patient care and share knowledge and expertise. By working as a team, Liebelt and their colleagues can provide comprehensive and coordinated care to patients with complex medical needs.
Liebelt's work has had a positive impact on many patients' lives by helping them manage their health conditions, improve their quality of life, and achieve better health outcomes. Their dedication to patient care and commitment to staying informed about the latest medical advancements have made a difference in the lives of those they treat.
Liebelt has also contributed to important publications and clinical trials, such as the study on genetic carrier screening published in The New England Journal of Medicine and the ongoing Mackenzie's Mission project. These contributions further demonstrate Liebelt's commitment to advancing medical knowledge and improving patient care.
Enrollment Status: Active not recruiting
Published: April 09, 2024
Intervention Type: Other
Study Drug:
Study Phase: Not Applicable
